Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674947 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT00674947 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 55 participants.
The verdict
NCT00674947, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
Phase 1, open-labeled, safety and tolerability study for the treatment of subjects with relapsed or refractory solid tumors.
Interventions
- DRUG BIIB015
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00674947
The ClinicalTrials.gov registry entry for NCT00674947 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BIIB015 is the first listed.
NCT00674947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00674947 about?
NCT00674947 is a clinical study titled "A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors". Phase 1, open-labeled, safety and tolerability study for the treatment of subjects with relapsed or refractory solid tumors.
What is the current status of trial NCT00674947?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2008-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00674947?
The interventions under investigation include: BIIB015 (DRUG).
Who is sponsoring clinical trial NCT00674947?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.